Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.22 USD | +1.83% | -4.72% | -60.54% |
May. 16 | Sector Update: Health Care Stocks Ease Thursday Afternoon | MT |
May. 16 | Oragenics to Start Phase 2 Concussion Treatment Drug Trial -- Shares Rise | MT |
Financials (USD)
Sales 2022 | 0.13 | Sales 2023 | 0.04 | Capitalization | 14.46M |
---|---|---|---|---|---|
Net income 2022 | -14M | Net income 2023 | -20M | EV / Sales 2022 | 11,842,208 x |
Net cash position 2022 | 10.8M | Net cash position 2023 | 3.16M | EV / Sales 2023 | 299,979,895 x |
P/E ratio 2022 |
-0.89
x | P/E ratio 2023 |
-0.61
x | Employees | 5 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 76.77% |
1 day | +1.83% | ||
1 week | -4.72% | ||
Current month | +114.49% | ||
1 month | +103.67% | ||
3 months | -32.32% | ||
6 months | -38.33% | ||
Current year | -60.54% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Redmond
CEO | Chief Executive Officer | 64 | Dec. 27 |
Janet Huffman
DFI | Director of Finance/CFO | 52 | 23-03-06 |
Kimberly Murphy
BRD | Director/Board Member | 62 | 20-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Pope
CHM | Chairman | 73 | 10-06-03 |
John Gandolfo
BRD | Director/Board Member | 63 | 23-10-03 |
Robert Koski
BRD | Director/Board Member | 65 | 09-06-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 2.22 | +1.83% | 44,379 |
24-05-23 | 2.18 | -13.15% | 53,123 |
24-05-22 | 2.51 | -17.43% | 836,022 |
24-05-21 | 3.04 | -0.98% | 214,417 |
24-05-20 | 3.07 | +31.76% | 1,200,444 |
Delayed Quote Nyse, May 24, 2024 at 04:10 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-60.54% | 9.95M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- OGEN Stock